Sustiva (efavirenz), a new antiviral for HIV that can be taken just ONCE a day

October 1998

DuPont is now marketing Sustiva (efavirenz), a new antiviral for HIV that can be taken just ONCE a day.

Sustiva is a non-nucleoside reverse transcriptase inhibitor (NNRTI)...in the same class as Rescriptor and Viramune.

It seems to be as potent as a protease inhibitor...when combined with Retrovir (zidovudine) and Epivir (lamivudine).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote